Topical hesperidin prevents glucocorticoid-induced abnormalities in epidermal barrier function in murine skin.
George Man, Theodora M Mauro, Peggy L Kim, Melanie Hupe, Yongjiao Zhai, Richard Sun, Debbie Crumrine, Carolyn Cheung, Almudena Nuno-Gonzalez, Peter M Elias, Mao-Qiang Man
Index: Exp. Dermatol. 23(9) , 645-51, (2014)
Full Text: HTML
Abstract
Systemic and topical glucocorticoids (GC) can cause significant adverse effects not only on the dermis, but also on epidermal structure and function. In epidermis, a striking GC-induced alteration in permeability barrier function occurs that can be attributed to an inhibition of epidermal mitogenesis, differentiation and lipid production. As prior studies in normal hairless mice demonstrated that topical applications of a flavonoid ingredient found in citrus, hesperidin, improve epidermal barrier function by stimulating epidermal proliferation and differentiation, we assessed here whether its topical applications could prevent GC-induced changes in epidermal function in murine skin and the basis for such effects. When hairless mice were co-treated topically with GC and 2% hesperidin twice-daily for 9 days, hesperidin co-applications prevented the expected GC-induced impairments of epidermal permeability barrier homoeostasis and stratum corneum (SC) acidification. These preventive effects could be attributed to a significant increase in filaggrin expression, enhanced epidermal β-glucocerebrosidase activity and accelerated lamellar bilayer maturation, the last two likely attributable to a hesperidin-induced reduction in stratum corneum pH. Furthermore, co-applications of hesperidin with GC largely prevented the expected GC-induced inhibition of epidermal proliferation. Finally, topical hesperidin increased epidermal glutathione reductase mRNA expression, which could counteract multiple functional negative effects of GC on epidermis. Together, these results show that topical hesperidin prevents GC-induced epidermal side effects by divergent mechanisms. © 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Related Compounds
Related Articles:
Curcumin relieves TPA-induced Th1 inflammation in K14-VEGF transgenic mice.
2015-04-01
[Int. Immunopharmacol. 25(2) , 235-41, (2015)]
Topical steroids for chronic wounds displaying abnormal inflammation.
2013-05-01
[Ann. R. Coll. Surg. Engl. 95(4) , 291-6, (2013)]
2012-11-01
[Journal. of. Drugs in. Dermatology. 11(11) , 1348-54, (2012)]
Clobetasol propionate spray 0.05% for the treatment of moderate to severe plaque psoriasis.
2012-02-01
[Cutis. 89(2) , 89-94, (2012)]
2014-11-01
[Pharm. Dev. Technol. 19(7) , 789-98, (2014)]